Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system. The company provides Elelyso for the treatment of Gaucher disease; and...
24 insider purchases on record · latest filing 2025-12-23.
Insiders have also filed 409 sale transactions at PLX.